Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients
- PMID: 28339964
- PMCID: PMC5464430
- DOI: 10.1093/neuonc/nox012
Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients
Figures
References
-
- Jiang T, Mao Y, Ma W, et al. ; Chinese Glioma Cooperative Group (CGCG). CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016;375(2):263–273. - PubMed
-
- Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997–1003. - PubMed
-
- Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
